Search Results - "Irvine, Jessica M."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
  2. 2
  3. 3

    Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians by Irvine, Jessica M, Hallvik, Sara E, Hildebran, Christi, Marino, Miguel, Beran, Todd, Deyo, Richard A

    Published in The journal of pain (01-07-2014)
    “…Prescription drug monitoring programs (PDMPs) are relatively new but potentially useful tools to enhance prudent prescribing of controlled substances. However,…”
    Get more information
    Journal Article
  4. 4

    How Clinicians Use Prescription Drug Monitoring Programs: A Qualitative Inquiry by Hildebran, Christi, Cohen, Deborah J., Irvine, Jessica M., Foley, Carol, O'Kane, Nicole, Beran, Todd, Deyo, Richard A.

    Published in Pain medicine (Malden, Mass.) (01-07-2014)
    “…Objectives Prescription drug monitoring programs (PDMPs) are now active in most states to assist clinicians in identifying potential controlled drug misuse,…”
    Get full text
    Journal Article
  5. 5

    Clinicians’ Use of Prescription Drug Monitoring Programs in Clinical Practice and Decision-Making by Leichtling, Gillian J., Irvine, Jessica M., Hildebran, Christi, Cohen, Deborah J., Hallvik, Sara E., Deyo, Richard A.

    Published in Pain medicine (Malden, Mass.) (01-06-2017)
    “…Abstract Objectives. Little is known about clinicians’ use of prescription drug monitoring program (PDMP) profiles in decision-making. The objective of this…”
    Get full text
    Journal Article
  6. 6

    Leading a Horse to Water: Facilitating Registration and Use of a Prescription Drug Monitoring Program by Deyo, Richard A, Irvine, Jessica M, Hallvik, Sara E, Hildebran, Christi, Beran, Todd, Millet, Lisa M, Marino, Miguel

    Published in The Clinical journal of pain (01-09-2015)
    “…Prescription Drug Monitoring Programs (PDMPs) can help inform patient management, coordinate care, and identify drug safety risks, abuse, or diversion…”
    Get full text
    Journal Article
  7. 7

    Clinical Styles and Practice Policies: Influence on Communication with Patients Regarding Worrisome Prescription Drug Monitoring Program Data by Hildebran, Christi, Leichtling, Gillian, Irvine, Jessica M., Cohen, Deborah J., Hallvik, Sara E., Deyo, Richard A.

    Published in Pain medicine (Malden, Mass.) (01-11-2016)
    “…Objectives. Clinician communication with patients regarding worrisome findings in Prescription Drug Monitoring Programs (PDMPs) may influence patient responses…”
    Get full text
    Journal Article
  8. 8

    Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions by Deyo, Richard A, Irvine, Jessica M, Millet, Lisa M, Beran, Todd, O'Kane, Nicole, Wright, Dagan A, McCarty, Dennis

    Published in Health Affairs (01-03-2013)
    “…In response to increasing abuse of prescription drugs, forty-four states have implemented--and five more states will soon adopt--monitoring programs to track…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11